Antipsychotic Switch Reverses Dangerous Metabolic Syndrome in Schizophrenia Patients
A six-month prospective study found that switching stable schizophrenia patients from olanzapine to aripiprazole reversed a high-risk metabolic syndrome subtype ...
A six-month prospective study found that switching stable schizophrenia patients from olanzapine to aripiprazole reversed a high-risk metabolic syndrome subtype ...
A two-stage analysis combining FDA adverse event reports with Japanese claims data found aripiprazole associated with a significantly lower risk ...
A new survey of patients and healthcare professionals from the phase 3 SOLARIS trial finds strong satisfaction with a once-monthly ...
A year-long study of 510 youths found that antipsychotics disrupt metabolism through two distinct pathways, one driven by fat gain ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine